Skip to main content
BusinessResearch

Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation

Source: SiliconANGLE (opens in a new tab) · Maria Deutscher

Intel Summary

SiliconANGLE reports, citing Bloomberg, that Alphabet spinoff Isomorphic Labs is in discussions to raise a new funding round targeting a valuation between $40 billion and $50 billion. The drug discovery company's total capital target for the round was not disclosed.

Why It Matters

If finalized, the targeted valuation would make Isomorphic Labs one of the highest-valued dedicated AI drug discovery entities globally, reflecting substantial commercial expectations for AI-driven biological modeling and pharmaceutical research.

Organizations & Entities

Topics